Doximity, Inc.
For the period ended Mar 31, 2026. Filed May 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 19, 2026
DOCS$32.42-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except per share data)
| As of March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $219,178 | $209,614 |
| Marketable securities | 529,423 | 706,050 |
| Accounts receivable, net of allowance for doubtful accounts of $1,345 and $1,937 as of March 31, 2026 and 2025, respectively | 144,783 | 128,354 |
| Prepaid expenses and other current assets | 50,880 | 44,602 |
| Total current assets | 944,264 | 1,088,620 |
| Property and equipment, net | 18,080 | 13,656 |
| Deferred income tax assets | 31,984 | 60,014 |
| Operating lease right-of-use assets | 7,140 | 8,886 |
| Intangible assets, net | 35,325 | 23,072 |
| Goodwill | 84,973 | 67,940 |
| Other assets | 1,921 | 2,121 |
| Total assets | $1,123,687 | $1,264,309 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $4,009 | $1,356 |
| Accrued expenses and other current liabilities | 42,804 | 38,405 |
| Deferred revenue, current | 106,050 | 114,285 |
| Operating lease liabilities, current | 2,110 | 2,211 |
| Total current liabilities | 154,973 | 156,257 |
| Deferred revenue, non-current | 400 | 280 |
| Operating lease liabilities, non-current | 8,075 | 10,185 |
| Contingent earn-out consideration liability, non-current | — | 5,579 |
| Other liabilities, non-current | 9,402 | 9,383 |
| Total liabilities | 172,850 | 181,684 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ Equity | ||
| Preferred stock, $0.001 par value; 100,000 shares authorized as of March 31, 2026 and 2025, respectively; zero shares issued and outstanding as of March 31, 2026 and 2025, respectively | — | — |
| Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March 31, 2026 and 2025, respectively; 183,060 and 188,875 shares issued and outstanding as of March 31, 2026 and 2025, respectively | 183 | 189 |
| Additional paid-in capital | 1,001,688 | 894,225 |
| Accumulated other comprehensive income | 28 | 1,323 |
| Retained earnings (accumulated deficit) | (51,062) | 186,888 |
| Total stockholders' equity | 950,837 | 1,082,625 |
| Total liabilities and stockholders’ equity | $1,123,687 | $1,264,309 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.